Öztürk Ateş
Impact in
-
- Cancer Risks and Factors
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Cancer survivorship and care
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 22
- Cancer Treatment and Pharmacology 6
- Cancer Diagnosis and Treatment 4
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 4
-
- Advanced Breast Cancer Therapies 6
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Kadri Altundağ (21 shared papers)Taner Babacan (13 shared papers)Ali Sever (8 shared papers)Neyran Kertmen (13 shared papers)Furkan Sarici (10 shared papers)Serkan Akın (14 shared papers)Yavuz Özışık (6 shared papers)Aydın Aytekin (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)SpringerPlus (1 paper)Annals of Oncology (1 paper)Anti-Cancer Drugs (1 paper)The Breast (1 paper)
- Partner nations
- TürkiyeUnited StatesIndia
In The Last Decade
Öztürk Ateş
48 papers receiving 286 citations
Peers
Comparison fields: 5 of 61
- Oncology 116
- Cancer Research 54
- Pulmonary and Respiratory Medicine 54
- Microbiology 1
- Pathology and Forensic Medicine 22
Countries citing papers authored by Öztürk Ateş
This map shows the geographic impact of Öztürk Ateş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Öztürk Ateş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Öztürk Ateş more than expected).
Fields of papers citing papers by Öztürk Ateş
This network shows the impact of papers produced by Öztürk Ateş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Öztürk Ateş. The network helps show where Öztürk Ateş may publish in the future.
Co-authors
The 25 scholars most cited alongside Öztürk Ateş, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 69 | |
| 2 | 2016 | 26 | |
| 3 | 2004 | 20 | |
| 4 | Molecular subtypes in patients with inflammatory breast cancer; a single center experience. | 2015 | 17 |
| 5 | Association between androgen receptor status and prognosis in triple negative breast cancer. | 2019 | 15 |
| 6 | 2012 | 10 | |
| 7 | The first line systemic chemotherapy in metastatic gastric carcinoma: A comparison of docetaxel, cisplatin and fluorouracil (DCF) versus cisplatin and fluorouracil (CF); versus epirubicin, cisplatin and fluorouracil (ECF) regimens in clinical setting. | 2011 | 10 |
| 8 | 2021 | 8 | |
| 9 | 2015 | 8 | |
| 10 | 2017 | 7 | |
| 11 | Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer. | 2016 | 7 |
| 12 | Efficacy of Pazopanib in patients with metastatic uterine sarcoma: A multi-institutional study. | 2020 | 7 |
| 13 | 2022 | 7 | |
| 14 | 2024 | 6 | |
| 15 | 2015 | 6 | |
| 16 | 2017 | 6 | |
| 17 | 2021 | 5 | |
| 18 | 2017 | 5 | |
| 19 | A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancer. | 2015 | 5 |
| 20 | Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers. | 2019 | 4 |
About Öztürk Ateş
Öztürk Ateş is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 63 papers that have together received 293 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (6 papers), Cancer Diagnosis and Treatment (4 papers), HER2/EGFR in Cancer Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Ovarian cancer diagnosis and treatment (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Oncology (116 citations), Cancer Research (54 citations), Pulmonary and Respiratory Medicine (54 citations), Microbiology (1 citation) and Pathology and Forensic Medicine (22 citations). Öztürk Ateş has collaborated with scholars based in Türkiye, United States and India. Frequent co-authors include Kadri Altundağ, Taner Babacan, Ali Sever, Neyran Kertmen, Furkan Sarici, Serkan Akın, Yavuz Özışık, Aydın Aytekin, Süleyman Şahin and Gökmen Umut Erdem. Their work appears in journals such as Journal of Clinical Oncology, SpringerPlus, Annals of Oncology, Anti-Cancer Drugs and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.